KIT and acute myeloid leukemia: Two previous studies have found that KIT mutation at diagnosis is also an adverse prognostic factor for post-transplant relapse in t(8;21) AML (8, 10), but it may not be as strong as post-transplant MRD when analyzed in a multivariate model (8).